Skip to main content
. 2014 Apr 28;171(10):2671–2684. doi: 10.1111/bph.12616

Figure 4.

Figure 4

Effect of CRP on the activity of PKC and Src kinase in HUVECs. HUVECs were pretreated with 10 μmol·L−1 DPI, or 30 μmol·L−1 DTT for 30 min, and then exposed to 20 μg·mL−1 CRP for 5 min. (A) PKC activity in the absence or presence of CRP, DPI + CRP, DTT + CRP, BIM I + CRP or PP2 + CRP. **P < 0.01 versus Ctr; P < 0.01 versus CRP; §P > 0.05 versus CRP; n = 4. (B) Src kinase activity in the absence or presence of CRP, DPI + CRP, DTT + CRP, BIM I + CRP or PP2 + CRP. **P < 0.01 versus Ctr; P < 0.01 versus CRP; §P > 0.05 versus CRP; n = 4.